Influenza A Viruses Replicate Productively in Mouse Mastocytoma Cells (P815) and Trigger Pro-inflammatory Cytokine and Chemokine Production through TLR3 Signaling Pathway by Di Meng et al.
fmicb-07-02130 January 10, 2017 Time: 16:35 # 1
ORIGINAL RESEARCH
published: 12 January 2017
doi: 10.3389/fmicb.2016.02130
Edited by:
Akio Adachi,
Tokushima University, Japan
Reviewed by:
Noemi Sevilla,
Instituto Nacional de Investigación y
Tecnología Agraria y Alimentaria,
Spain
Qinfang Liu,
Shanghai Veterinary Research
Institute, China
*Correspondence:
Yanxin Hu
huyx@cau.edu.cn
Lunquan Sun
lunquansun @csu.edu.cn
†These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Virology,
a section of the journal
Frontiers in Microbiology
Received: 07 May 2016
Accepted: 16 December 2016
Published: 12 January 2017
Citation:
Meng D, Huo C, Wang M, Xiao J,
Liu B, Wei T, Dong H, Zhang G,
Hu Y and Sun L (2017) Influenza
A Viruses Replicate Productively
in Mouse Mastocytoma Cells (P815)
and Trigger Pro-inflammatory
Cytokine and Chemokine Production
through TLR3 Signaling Pathway.
Front. Microbiol. 7:2130.
doi: 10.3389/fmicb.2016.02130
Influenza A Viruses Replicate
Productively in Mouse Mastocytoma
Cells (P815) and Trigger
Pro-inflammatory Cytokine and
Chemokine Production through TLR3
Signaling Pathway
Di Meng1†, Caiyun Huo1†, Ming Wang1,2, Jin Xiao1,2, Bo Liu1, Tangting Wei1, Hong Dong3,
Guozhong Zhang1, Yanxin Hu1* and Lunquan Sun4*
1 Key Laboratory of Animal Epidemiology and Zoonosis of Ministry of Agriculture, College of Veterinary Medicine, China
Agricultural University, Beijing, China, 2 Key Laboratory of Veterinary Bioproduction and Chemical Medicine of the Ministry of
Agriculture, Zhongmu Institutes of China Animal Husbandry Industry Co., Ltd, Beijing, China, 3 Beijing Key Laboratory of
Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, Beijing, China, 4 Center for Molecular Medicine,
Xiangya Hospital, Central South University, Changsha, China
The influenza A viruses (IAVs) cause acute respiratory infection in both humans and
animals. As a member of the initial lines of host defense system, the role of mast
cells during IAV infection has been poorly understood. Here, we characterized for the
first time that both avian-like (α-2, 3-linked) and human-like (α-2, 6- linked) sialic acid
(SA) receptors were expressed by the mouse mastocytoma cell line (P815). The P815
cells did support the productive replication of H1N1 (A/WSN/33), H5N1 (A/chicken/
Henan/1/04) and H7N2 (A/chicken/Hebei/2/02) in vitro while the in vivo infection of
H5N1 in mast cells was confirmed by the specific staining of nasal mucosa and lung
tissue from mice. All the three viruses triggered the infected P815 cells to produce pro-
inflammatory cytokines and chemokines including IL-6, IFN-γ, TNF-α, CCL-2, CCL-5,
and IP-10, but not the antiviral type I interferon. It was further confirmed that TLR3
pathway was involved in P815 cell response to IAV-infection. Our findings highlight the
remarkable tropism and infectivity of IAV to P815 cells, indicating that mast cells may be
unneglectable player in the development of IAV infection.
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INTRODUCTION
Influenza A virus (IAV) is one of the most common respiratory pathogen in humans and animals.
Since the first outbreak in Hong Kong in 1997, the highly pathogenic avian influenza (HPAI)
H5N1 virus has become a public health threat due to its potential to cause serious illness and
death in humans (Uyeki, 2009). Virus-induced acute lung injury or its more severe form, acute
respiratory distress syndrome (ARDS), is a major cause of mortality by pandemic influenza and
HAPI H5N1 infections; however, the exact mechanism of this injury is not fully understood. Several
studies suggest that the main contributing factor is an increased production of inflammatory
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cytokines or “cytokine storm” (Thuy et al., 2011). This response
may result from each individual cell producing more cytokines,
or through chemokines-induced recruitment of a greater number
of innate immune cells into the lung (Teijaro et al., 2011). Thus,
the cellular sources involved in the resulting cytokine storm
remain undetermined.
Mast cells are enriched near epithelial surfaces exposed to
the external environment, and thus function as sentinels in
the defense against host infection, they also play a role in
initiating adaptive immune responses (Shelburne and Abraham,
2011). These processes are aided by the expression of a
unique ‘armamentarium’ of receptor systems and mediators
for responding to pathogen-associated signals (Marshall, 2004).
Mast cells are crucial for optimal immune responses against
bacterial, parasitic, and viral infections (Marshall, 2004). It was
well demonstrated that mast cells played important roles in the
pathogenesis of some viral infections, such as HIV-1, dengue
virus, cytomegalovirus and bovine respiratory syncytial virus
(Gibbons et al., 1990; King et al., 2000; Jolly et al., 2004;
Sundstrom et al., 2004; Shirato and Taguchi, 2009). We previously
demonstrated that mast cells were activated by H5N1 virus
infection and escalated lung injury (Hu et al., 2012). However,
it remains to be determined how this response is initiated,
and whether IAV can infect and efficiently replicate in mast
cells.
Influenza viruses bind to neuraminic acids (sialic acids, SA)
on the surface of cells to initiate infection and replication (Knipe
et al., 2001). The expression of SA linkages is cell type specific.
For example, α-2,3-SA receptors are detected specifically in
ciliated cells, while α-2,6-SA receptors are exclusively present
in non-ciliated cells (Matrosovich et al., 2004). Historically, α-
2,6-linked SA receptors, which are preferentially recognized by
human influenza viruses, are detected exclusively in cells of
upper respiratory tract of humans. However, both the α-2,6-
linkages and α-2,3- linkages are present in the human lower
respiratory tract, predominantly recognized by human and avian
influenza viruses respectively (Raman et al., 2014). Thus, the
type and distribution of SA is an important determinant of
influenza virus tropism and pathogenesis (Suzuki et al., 2000);
yet, little is known about SA receptor expression on mast
cells.
During IAV infection, influenza viral dsRNA is sensed through
several classes of pattern-recognition receptors (PRRs) including
Toll-like receptors (TLRs) and retinoic acid-inducible gene-
I-like receptors (RLRs) (Yu and Levine, 2011). Among the
PPRs, toll-like receptor 3 (TLR3) and cytolytic RNA helicases
retinoic acid-inducible gene I (RIG-I) are the most common
transducers of viral dsRNA signals. Once stimulated with their
respective agonist, TLR3 recruits adaptor molecule TIR-domain
containing adaptor inducing interferon-β (TRIF), while RIG-
I associated with mitochondrial antiviral signaling (MAVS) to
initiate downstream signaling. Both these pathways activate
the transcription factor nuclear factor (NF)-kB, leading to
the production of inflammatory cytokines, chemokines, and
activation of interferon regulatory factor (IRF) 3 and/or 7 to
induce the key antiviral mediator type I IFNs (Takeuchi and
Akira, 2009). Recently, Le Goffic et al. (2007) demonstrated the
importance of TLR3 in the inflammatory cytokine response to
IAV in lung epithelial cells in vitro (Le Goffic et al., 2007). IAV-
TLR3 interactions are also critical for viral pathology in vivo.
Previous studies showed that the association between RIG-I and
viral ssRNA bearing an uncapped 5′-triphosphate end (Pichlmair
et al., 2006) and this association resulted in the production of
IFNs (Kato et al., 2006). Moreover, RIG-I played a key role in the
expression of proinflammatory cytokines in mast cells infected by
IAV. However, the role of TLR3 during IAV infection in mast cells
remains unexplored.
Therefore, in the present study we sought to determine the
presence and role of SA receptors on mouse mastocytoma cell
line (P815). We demonstrated that P815 cells expressed both α-
2, 3-, and α-2, 6- linked SA receptors to initiate IAV infection.
In addition, P815 cells supported productive replication of IAVs
in vitro while the in vivo infection of H5N1 in mast cells was
confirmed by the specific staining of nasal mucosa and lung
tissue from mice. Following IAV infection, P815 cells mediated
substantial hyper-induction of pro-inflammatory cytokines and
chemokines, and TLR3 signal pathways probably involved in
the process. This provides insight for the development of novel
strategies to combat influenza infection by targeting mast cells.
MATERIALS AND METHODS
Ethics Statement
All mouse experimental protocols complied with the guidelines
of the Beijing Laboratory Animal Welfare and Ethics Committee,
and were approved by the Beijing Association for Science
and Technology (the approval ID is SYXK-2009-0423). All
experiments with live H5/H7 subtype viruses were performed in
a biosafety level 3 containment laboratory (the approval number
is CNAS BL0017) approved by the Ministry of Agriculture of the
People’s Republic of China.
Viruses and Cells Culture
The avian influenza viruses H5N1 (A/Chicken/Henan/1/04) (Hu
et al., 2012) and H7N2 (A/Chicken/Hebei/2/02) were isolated
from infected chicken flocks, and propagated in the allantoic
cavities of 10-day-old embryonated chicken eggs for 24–48 h
at 37◦C. The working stocks of human influenza virus H1N1
(A/WSN/33) were generated in MDCK cells. Virus titers were
determined by standard plaque assays. The 50% lethal dose
(LD50) in mice was determined as previously described (Hu et al.,
2012). The mouse mastocytoma cell line P815 and the Madin-
Darby canine kidney cell line MDCK were cultured as previously
described (Hu et al., 2012).
In vitro Viral Infection and LE-PolyI:C
Treatment
Cell monolayers were formed in tissue culture plates by seeding
6-well (1 × 106 cells/well) or 12-well (5 × 105 cells/well) plates,
washed with DMEM and infected with viruses at a multiplicity
of infection (MOI) of 0.1 for 1 h at 37◦C. After incubation, cells
monolayers were washed and DMEM supplemented with 1%
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bovine serum albumin was added to each well and incubated
for the indicated times. Polyinosine-polycytidylic acid (polyI:C),
a synthetic mimic of viral double-stranded RNA, was used as
a positive control. Liposome-encapsulated PolyI:C (LE-PolyI:C)
used in this study was prepared as described previously (Wong
et al., 1999), diluted to a final concentration of 10 µg/ml and
incubated with cells at 37◦C for the indicated times.
In vivo Viral Challenge
Female BALB/c mice (8–10 weeks) were purchased from Vital
River Laboratories (Beijing, China), and feed pathogen-free food
and water in independent ventilated cages. Mice were first
anesthetized with Zotile R© (Virbac, Carros, France), and then
infected intra-nasally with PBS-diluted H5N1 virus (5LD50) or
PBS alone. The nose and lung tissues were then collected 6 days
post-infection.
Immunofiuorescence Staining and
Confocal Microscopy
Tissue samples were fixed in 4% neutral formalin, embedded in
paraffin, and serially cut at a thickness of 5 µm. Cultured cells
were fixed on a polylysine-coated slide with 4% formaldehyde,
and blocked with 3% BSA. To visualize surface receptors,
slides containing fixed tissues or cells were directly stained
with fluorescein- Sambucus nigra bark lectin (SNA, specific
to SAα2,6-Gal) or fluorescein- Maackia amurensis lectin I
(MAA-I, specific to SAα2,3-Galβ(1-4)GlcNAc). To confirm the
specificity of lectin binding, monolayers were washed and
treated with 250 mU/ml of neuraminidase from Clostridium
perfringens (New England BioLabs, Beijing, China) for 3 h
prior to lectin staining. To detect tryptase expression or IAV
nucleoprotein (NP) antigen, cells were permeabilized with 0.5%
Triton X-100 before blocking, then tissue sections or cell slides
were either incubated with a rabbit anti-mast cell tryptase
monoclonal antibody (Abcam, [EPR8476], ab134932) for 2 h
at room temperature, or a mouse anti-IAV NP monoclonal
antibody (Abcam [AA5H], ab20343) at 4◦C overnight. After
washing three times with PBS-T, tissue sections were further
incubated with a Texas red-conjugated goat anti-mouse or
rabbit secondary antibody, and cell slides were incubated
with a FITC-conjugated goat anti-mouse secondary antibody
(Abcam) for 1 h at room temperature. To visualize the
nuclei, all slides were stained with 3 µg/ml 4′,6′-Diamidine-
2-phenylindole (DAPI) (Sigma–Aldrich) for 5 min at room
temperature and then examined under a laser scanning confocal
microscope (Leica TCS SP5 II, Leica Microsystems, Wetzlar,
Germany).
Flow Cytometry Analysis
Cultured P815 cells (1 × 106) were pelleted, washed twice with
DMEM, once with flow buffer (PBS with 2% FBS) and then re-
suspended in 200 µl of fluorescein- SAA or fluorescein- MAA I
at different dilutions. The cells were incubated for 1 h at 4◦C, then
washed and re-suspended in flow cytometry buffer for analysis on
a BD FACSCalibur using Cell Questpro software (BD Biosciences,
California).
Transmission Electronmicroscopy (TEM)
Cells were trypsinized and fixed using 2.5% (v/v) glutaraldehyde
in PBS for 2 h at 4◦C. Cells were then washed with PBS, post-fixed
in 1% osmium tetroxide, and washed and dehydrated in series
of ethanol solutions. The dehydrated pellets were embedded in
epoxy resin, and 70-nm sections were cut. Then the sections were
placed on copper sieves and stained with uranyl acetate and lead
citrate. Images were obtained using a JEM-1230 TEM (JEOL,
Japan Electronics Co., Ltd, Tokyo, Japan).
Real-Time Quantitative PCR
Total RNA was extracted from cells in Trizol reagents
(Invitrogen, Carlsbad, CA, USA). DNase I-treated RNA (0.2 µg)
was reverse transcribed into cDNA using random or universal
primers for IAV (Uni 12) (Hoffmann et al., 2001) with an
EasyScript First-Strand cDNA Synthesis Super Mix (TransGen
Biotech, China) according to the manufacturer’s instruction.
Reactions were performed in triplicate using a Power SYBR R©
Green PCR Master Mix (Applied Biosystems, Warrington, UK)
and the Applied Biosystems 7500 system. The mRNA expression
levels of the genes were normalized to β-actin, compared with
mock-infected cells, and quantified by the 2−11CT method. The
sequences of the primers are listed in Supplementary Table S1.
The amplifications were performed as follows: a 10 min hot start
at 95◦C, followed by 40 cycles of denaturation at 95◦C for 15 s,
annealing at 55◦C for 35 s, and extension at 72◦C for 40 s.
Proteome Profiler Antibody Array Assay
Cell-free supernatants were acquired by centrifugation, then
the levels of cytokines and chemokines were analyzed by the
Mouse Cytokine Array Panel A (R&D Systems, Minneapolis,
MN, USA) according to the manufacturer’s instructions, which
could provide parallel determination of the relative levels of 40
kinds of selected mouse cytokines and chemokines.
Cytokine and Chemokine Quantification
The concentration of IL-6, IFN-γ, RANTES, IP-10, IFN-α, IFN-
β, and TNF-α in the supernatant of cell cultures was determined
using ELISA kits (eBioscience, San Diego, CA, USA) according to
the manufacturer’s instructions.
Co-immunoprecipitation
Cells were either mock-treated, LE-PolyI:C-treated, or infected
with IAV viruses at a MOI of 0.1. At 6 h post-infection, the
cells were washed with cold PBS and lysed for 15 min on ice
with RIPA lysis buffer containing 50 mM Tris-HCl (pH7.4),
150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate and a
protease inhibitor cocktail (Beyotime Institute of Biotechnology,
Beijing, China). Lysed cells were pelleted and the supernatants
were incubated with the indicated antibodies (anti-TLR3
antibody or an isotype IgG antibody from Abcam) for 2 h
at 4◦C with gentle shaking. The samples were then added
to a preprocessed EZviewTM Red Protein A/G Affinity Gel
(Sigma) and incubated for 6 h. After washing three times
with lysis buffer, the beads were boiled in SDS loading
buffer, and then analyzed by immunoblot with the indicated
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antibodies (anti-TLR3 antibody or anti-TRIF antibody from
Abcam).
Western Blot
Cell lysates were prepared using lysis buffer as described
above, and protein concentrations were determined using a
BCA protein assay kit (Beyotime Institute of Biotechnology).
Equal amounts of protein were separated by SDS-PAGE and
transferred to a polyvinylidene difluoride (PVDF) membrane
(Millipore, Beijing, China). The membranes were blocked using
5% non-fat dry milk (BD Biosciences) at room temperature
for 2 h, and then incubated overnight at 4◦C with antibodies
(anti-TLR3 antibody and anti-TRIF antibody from Abcam;
Influenza A NS1 antibody from Santa Cruz Biotechnology,
Dallas, Texas, USA). After three 10 min washes in Tris-buffered
saline containing 0.05% Tween (TBST), the membranes were
incubated for 1 h at room temperature with the appropriate
horseradish peroxidase-conjugated secondary antibody. Protein
bands were visualized using the Western Lightning Plus-ECL
(Perkin Elmer, MA, USA). β- Actin was used as a loading
control.
Inhibition of TLR3 Activation Using
Specific Inhibitions
P815 cell monolayers were pre-incubated with TLR3/dsRNA
complex inhibitor (Calbiochem, Darmstadt, Germany) at a
concentration of 25 and 50 µM (diluted with DMSO) for 12 h.
They were then were infected with virus at a MOI of 0.1, exposed
to LE-PolyI:C, or mock treated as described above. The same
concentration of inhibitors was immediately added after 1 h
of viral incubation. Samples were collected 24 and 36 h after
infection.
Statistical Analysis
Statistical analysis was performed by one-way ANOVA using
the SPSS software suite (version 12.0), and a P-value of <0.05
was considered statistically significant. Results were expressed as
mean ± standard deviation (SD) of at least three independent
experiments.
RESULTS
P815 Cells Express Both α-2,3- Linked
and α-2,6- Linked SA Receptors
Influenza viral HA proteins initiate infection by interacting
with sialic acid residues coating the surface of host cells.
In general, human influenza viruses and S. nigra bark lectin
(SNA) preferentially bind α-2,6- linked SA receptors, while
avian influenza viruses and M. amurensis lectin (MAA)
predominantly bind to α-2,3- linked SA receptors (Springer
et al., 1969; Suzuki et al., 2000; Ibricevic et al., 2006; Shinya
et al., 2006). Here we used the mouse mastocytoma cell line,
P815, as a mast cell model. To determine the susceptibility
of P815 cells to influenza viruses, we first analyzed the
distribution of surface SA receptors by lectin staining as
described in the materials and methods. Both α-2,3- and α-
2,6- linked SA receptors were expressed on the surface of
P815 mouse mastocytoma cells, with the intensities of SNA
being visually stronger than one of the two isoforms of MAA
(Figure 1A). We treated P815 cells with a broad-spectrum
neuraminidase to cleave sialic moieties abolished lectin binding,
and confirmed the specificity of SNA and MAA staining
(Figure 1A, insets).
To quantitatively analyze the sialic acid residues, P815
cells were stained with different concentrations of FITC-
conjugated lectins and assayed by flow cytometry. As
shown in Figure 1B, at an lectin concentration of 5 µg/ml,
95.54% of P815 cells were detected positive expression of
α-2,3-linked SA receptors (FITC-MAA) and 98.57% of α-
2,6-linked receptors (FITC-SNA). At higher concentrations
(10 and 20 µg/ml), almost all cells positively expressed
both SA receptors (>99%). The mean fluorescence intensity
(MFI) depended on the lectin concentration, and the MFI
of SNA was significantly higher (>fivefold) than that of
MAA at all the concentrations. These data suggested that
the expression of α-2,6- linked SA receptors was more
abundant on P815 mastocytoma cells than α-2,3- linked SA
receptors.
Taken together, these data suggested that both α-2,3- and α-
2,6- linked SA receptors were expressed on the surface of P815
mouse mastocytoma cells.
P815 Cells Support the Replications of
IAVs
We previously demonstrated that H5N1 infection could
activate mast cells (Hu et al., 2012). To determine if IAV
could enter and replicate productively in mastocytoma cells,
we examined the replication kinetics of human and avian
IAVs in P815 cells. As shown in Supplementary Figure S1,
all three subtypes of IAVs productively replicated in P815
cells as measured by hemagglutination assay (left), plaque
formation (middle), and viral RNA expression (right). In P815
cells, the replications H1N1 and H5N1 viruses were more
efficient than H7N2 virus. These data indicated that IAVs
replicated well in P815 cells with some degree of tropism
selectivity.
To corroborate this finding, P815 cells were co-stained with α-
2,3- or α-2,6- linked SA receptors and viral NP (Figure 2A). The
wide distribution of α-2,6- linked SA receptors was consistent
the effective replication of H1N1. In addition, a large number
of NP-positive cells were observed when infected with H5N1,
but were less abundant in H7N2 infected cells, which was
consistent with the viral replication profiles (Supplementary
Figure S1). To further validate the permissiveness of P815 for
IAVs replication, we used transmission electron microscopy.
As shown in Figure 2B, budding virions were present on the
surface of cells infected with each of the three virus subtypes.
Moreover, many viral particles were found to be associated
with the surface of the cells infected with H1N1 and H5N1,
but were less obvious on H7N2 infected cells. Together, the
above data suggested that IAVs could bind and enter into
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FIGURE 1 | P815 cells express α-2, 3- and α-2,6- linked sialic acid (SA) receptors. (A) The mouse mastocytoma cell line P815 was placed on
polylysine-coated slides and stained with FITC-conjugated SNA or MAA-I (green), and DAPI (blue) for nuclei. Image inserts depict cells pre-treated with
neuraminidase to abolished sialic acid residue staining. (B) Trypsinized P815 cells were incubated with FITC-conjugated SNA or MAA-I (concentrations from left to
right are 5, 10, and 20 µg/ml) and analyzed using flow cytometry to determine relative percentages of cells expressing α-2,3-SA (MAA, pink) or α-2,6-SA (SNA,
green), compared to unstained cells (black). “NA-MAA” and “NA-SNA” indicated that P815 cells pre-treated with neuraminidase to abolished sialic acid residue
staining. Results shown are representative of three independent experiments.
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FIGURE 2 | Influenza viruses can infect P815 cells in vitro. P815 cells were mock-treated or infected with three subtypes of influenza viruses at a MOI of 0.1.
(A) Immunofluorescence detection of viral nucleoprotein (NP) antigen and SA receptors in P815 cells. At the indicated times post-infection, cells were fixed and
stained for α-2,6- or α-2,3- sialic acids (green) and influenza NP (red). Results shown are representative of three separate experiments. (B) Transmission electron
microscopy of influenza viruses released from the cell surface. Higher magnifications are in the boxes on the right. Arrows denote the virus particles.
P815 mastocytoma cells, where the efficient replication was
supported.
To determine if IAVs can infect mast cells in vivo, we used
a mouse H5N1 virus infection model. Mice were either infected
with H5N1 or PBS and the nasal mucosa and lung tissues
were resected and analyzed by immunofluorescence. Cells double
positive for the virus-specific antigen NP and the mast cell
specific protein tryptase were present in H5N1 infected mice but
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FIGURE 3 | H5N1 influenza virus can infect mouse mast cells in vivo. Representative nasal mucosa and lung sections from control or H5N1 virus-infected
mice. Sections were analyzed by immunofluorescence staining (Blue = nuclei, red = tryptase, and green = influenza NP). Results shown are representative of three
independent repeats.
not in PBS treated mice (Figure 3). These data suggested that
IAVs probably could actively infect mast cells in vivo.
IAVs Induce Cytokine and Chemokine
Production in P815 Cells
Our previous data suggested that H5N1-activated mast cells
could intensify lung injury by releasing the pro-inflammatory
mediators including histamine, tryptase, and IFN-γ (Hu
et al., 2012). To more specifically examine the cytokines and
chemokines released by P815 cells upon avian and human IAVs
infection, we performed an antibody array analysis. As shown
in Figure 4A, the production of sICAM-1, IL-6, IL-13, IP-
10, M-CSF, CCL-2, CCL-12, and TNF-α was augmented in
the supernatants of P815 cells infected with all three viruses
subtypes. The release of G-CSF, GM-CSF, CCL-1, IFN-γ, IL-
1α, IL-4, and CXCL-1 was only moderately increased. To
further confirm these findings, we used ELISA to conduct
kinetic profiles of the selected cytokines and chemokines that
were potentially involved in responses to influenza infection.
The three virus subtypes, and LE-PolyI:C, induced significantly
higher levels of IL-6 and IFN-γ compared to mock treated
cells (Figure 4B). The production of CCL-2 did not occur
until 12 h post-infection, but then increased from 24 to 48 h
post-infection (Figure 4B), while the secretion of IP-10 and
TNF-α increased gradually peaking at 36 h post-infection.
In contrast, all three IAV subtypes induced a relatively low
expression of CCL-5 for 24 h post-infection, but this increased
at later time points. The expressions of antiviral cytokines IFN-
α and IFN-β did not change from 2 to 48 h post-infection
(Figure 4B).
To further analyze the expression kinetics of various cytokines
and chemokines released by P815 cells infected with each of the
three virus subtypes and LE-PolyI:C, we performed quantitative
RT-PCR. The mRNA expression profiles of IL-6, IFN-γ, TNF-α,
CCL-2, CCL-5, and IP-10 were similar to the data generated from
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FIGURE 4 | Influenza virus infection causes the release of pro-inflammatory cytokines and chemokines. (A) P815 cells were infected with H1N1, H5N1,
and H7N2 at a MOI of 0.1, or mock treated for 24 h. Cell-free supernatants were then analyzed for cytokine and chemokine content using a cytokine array panel.
Numbered boxes denote up-regulated expression, with the most dramatic increases annotated in bold. Results shown are representative of two separate
experiments. (B) P815 cells were infected with H1N1, H5N1, and H7N2 at a MOI of 0.1, exposed to LE-PolyI:C, or mock treated. At the designated time points, cell
supernatants were harvested and the expression of IL-6, IFN-γ, CCL-2, CCL-5, IP-10 TNF-α, IFN-α, and IFN-β was analyzed by ELISA. Graphs shown are
mean ± SD of three independent replicates. Asterisks indicate statistically significant increases compared to mock treatment (∗P < 0.05, ∗∗P < 0.01). ND, not
detectable.
ELISA (Supplementary Table S2). However, while the expression
levels of a large number of pro-inflammatory cytokines and
chemokines were up-regulated, the mRNA levels of the antiviral
genes IFN-α, IFN-β and the anti-inflammatory cytokine IL-10
were unchanged during viral infection (Supplementary Table S2).
Taken together, these data suggested that following IAV infection
P815 cells released a range of pro-inflammatory cytokines and
chemokines.
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FIGURE 5 | Influenza A viruses up-regulates the expressions of TLR3 and TRIF mRNA and proteins. P815 cells were treated or infected as described in
Figure 4B. (A) Total RNA was isolated at the designed times and examined with quantitative real-time PCR. The expression of TLR3and TRIF is shown. The data are
presented as the relative fold change over mock treatment, and are pooled from three independent experiments. (B) P815 cells were collected at 2, 6, 12, and 24 h
post-infection or treatment, and then analyzed by immunoblotting for expression of TLR3, TRIF, viral NS1 protein and β-actin. Data are representative of three
separate experiments. (C) Endogenous interactions of TLR3 with TRIF. Whole cell extracts at 6 h (TLR3-TRIF) post-infection were immunoprecipitated with the
indicated antibodies or isotype IgG controls and analyzed by western blot analysis.
TLR3 Plays a Key Role in the Expression
of Proinflammatory Cytokines in P815
Cells Infected by IAV
Given that IAVs could infect P815 cells and promote the release
of inflammatory cytokines and chemokines, we next examined
expression level of viral RNA sensor TLR3 involved in the
transduction of inflammatory molecule signals. The mRNA
expression level of TLR3 in P815 cells infected with IAVs
peaked 4 h post-infections, and returned to baseline levels
by 12 h post-infection (Figure 5A). In addition, the mRNA
expression profiles of the adaptor molecules TRIF increased in a
manner consistent with TLR3 levels; however, the fold increase
compared to mock infected cells was much lower. Consistent
with mRNA levels, the protein expression of TRL3 and TRIF was
strongly augmented in IAV infected P815 cells (Figure 5B). To
confirm if TLR3 were indeed activated, co-immunoprecipitation
experiments were used to test the endogenous interactions of
TLR3 with TRIF. Co-precipitation of TLR3/TRIF was evident
in P815 cells infected with all three IAVs (Figure 5C). These
data indicated that the viral RNA sensors TLR3 were expressed
following IAV infection.
To further investigate the role of TLR3 in P815 cells
during IAV infection, we utilized a novel TLR3/dsRNA complex
inhibitor to disrupt the interaction between IAV and TLR3 in
P815 cells. The effects of the inhibitors on the release of pro-
inflammatory cytokines and chemokines, including IL-6, IFN-γ,
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FIGURE 6 | Toll-like receptors/dsRNA complex inhibitor can reduce the releasing of proinflammatory cytokines in P815 cells infected by IAV. P815
cells treatment with TLR3/dsRNA complex inhibitor were infected with H1N1, H5N1, and H7N2 at a MOI of 0.1, exposed to LE-PolyI:C, or mock treated. At the
designated time points, cell supernatants were harvested and the expression of TNF-α, IL-6, IFN-γ, and CCL-2 was analyzed by ELISA. Graphs shown are
mean ± SD of three independent replicates. Asterisks indicate statistically significant increases compared to mock treatment (∗P < 0.05, ∗∗P < 0.01).
TNF-α, and CCL-2, were examined. The expression of these
pro-inflammatory cytokines and chemokines was significantly
decreased in TLR3/dsRNA complex inhibitor treatment group
24 and 36 h after infection (Figure 6). In addition, treatment
of IAV-infected P815 cells with TLR3/dsRNA complex inhibitor
dramatically decreased viral titers 24 and 36 h after infection
(Figure 7). Taken together, these data suggested that following
IAV infection P815 cells actively participated in promoting
inflammation by releasing a range of pro-inflammatory cytokines
and chemokines possibly through TLR3 signaling pathways.
DISCUSSION
Elucidating the mechanisms of immune defense against IAV is
critical for developing therapeutic strategies to prevent influenza
infection. The role of endothelial cells, macrophages, and
dendritic cells in preventing infection in the respiratory tract
has been described (Bender et al., 1998; Julkunen et al., 2000).
However, mast cells, an important cell type in the first lines of
host immunity and defense, have been largely overlooked until
recently, data from our lab and others have demonstrated a
possible involvement of mast cells in IAV infection (Hu et al.,
2012; Graham et al., 2013; Marcet et al., 2013). Our previous
study showed that mast cells actively participate in the first-
line immunological responses to IAV infection. Mast cells could
aggravate pathological injury of the H5N1 virus infected tissues
in mice by directly inducing apoptosis or inflammatory cytokines
and mediators (Hu et al., 2012). However, the receptor repertoire
facilitating IAV infection and the cellular response in mast cells
are still largely unknown. The present work demonstrated that
the mouse mastocytoma cell line (P815) expressed both α-2,3-
and α-2,6- linked SA receptors to initiate IAV entry and could
serve as a comfortable environment for virus replication and
release progeny viruses.
In order to infect cells, IAV must first attach to SA receptors
on the plasma membrane. We demonstrated that both α-2,3-
and α-2,6- linked SA receptors were expressed on the surface
of P815 mouse mastocytoma cells. To our knowledge, this is
the first time SA receptors have been reported on the surface of
cells considered as mast cells. In addition, our data demonstrated
that P815 cells supported the productive replication of IAV. All
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FIGURE 7 | Toll-like receptors/dsRNA complex inhibitor can decrease the viral loads of IAV in P815 cells. P815 cells treatment with TLR3/dsRNA complex
inhibitor were infected with H1N1, H5N1, and H7N2 at a MOI of 0.1, exposed to LE-PolyI:C, or mock treated. Cells were homogenized in Trizol and relative viral NS
gene quantification was determined by real time PCR (A). Culture supernatants were collected at the indicated times post-infection, and virus titers in the
supernatants were determined by plaque assay (B). Results shown are pooled from three independent repeats. Asterisks indicate statistically significant increases
compared to mock treatment (∗P < 0.05, ∗∗P < 0.01).
three subtypes of the viruses (H1N1, H5N1, and H7N2) infected
and replicated in P815 cells in vitro, with images of transmission
electron microscope as the most powerful evidences. Though
the mouse mastocytoma cell line, P815, as a cell model, has
been widely used in mast cell-based research (Ohtsu et al., 1996;
Lunderius et al., 2000; Zhang et al., 2009, 2010), the validity
of data from this model should be verified by in vivo study or
with primary cells. In our present study, the infection of mast
cells with H5N1 in mice (in vivo) provided further evidence.
Contradictory with the results in P815 mouse mastocytoma cells,
Marcet’s study showed that H1N1 virus were limited replication
in human mast cells (Marcet et al., 2013). Similarly with our
results in the present study, several groups showed that dengue
virus could infect and replicate within mast cells (St John et al.,
2011). Whether mast cells can be infected and serviced as a
potent reservoir for persistent Human Immunodeficiency Virus
was still a debate until now (Sundstrom et al., 2007). Thus, our
findings provided new insights into the role of mast cells for the
pathogenesis of influenza.
Activated mast cells can selectively release many pro-
inflammatory cytokines and chemokines, which can vary
greatly depending on the stimulus and experimental conditions
(Abraham and St John, 2010). Here, we found that all the
three subtypes of IAVs infected P815 mouse mastocytoma cells
produced several cytokines, including a significant increase in
the expression of IL-6, IFN-γ, and TNF-α, which could serve as
objective markers of the host inflammatory responses and lung
injury (Hierholzer et al., 1998; Perrone et al., 2010). Additionally,
the chemokines CCL-2 and IP-10 were also increased, which
was consistent with observations from both clinical settings and
animal models (Zhou et al., 2006). Our results were consistent
with a recent report that bone marrow-cultured mast cells
infected by the influenza strain A/WSN/33 were found to release
several mediators (Graham et al., 2013). Our findings showed
that the three subtypes of IAVs induced similar cytokine and
chemokine kinetics, and the magnitude of responses induced by
H7N2 was much lower than H1N1 and H5N1, which exactly
related to the viral replication competence but not the origin
of the virus. We also found that the kinetic expression patterns
of gene transcription were different for various cytokines and
chemokines in P815 cells, some of them were likely directly
induced by IAV infection as the time courses of their appearance
were early, while others might result from autocrine or paracrine
feedback as the late appearance. Interestingly, even though type I
interferons are key antiviral cytokines produced by IAV-infected
epithelial cells and monocytes/macrophage (Hofmann et al.,
1997; Ronni et al., 1997), neither IFN-α nor IFN-β was detected
in P815 cells. We speculate that mast cells are involved in the
immune and inflammatory responses to AIV infection, but may
not directly participate in the antiviral mechanisms.
Mast cells used TLR3, RIG-I and MDA5 to sense viral RNA
following infection (Kulka et al., 2004; Oldstone and Rosen,
2014; Becker et al., 2015). In a Newcastle disease virus infection
model, mast cells produced cytokines and chemokines in a TLR3-
dependent manner (To et al., 2001). In addition, though the
degranulation and the generation of eicosanoid in mast cells
augmented the vascular leakage and played an important role
in dengue virus infection (St John et al., 2013; Syenina et al.,
2015), the roles of pattern recognition receptors against the
viral infection were also indispensable. Moreover, mast cells
infected with dengue virus and vesicular stomatitis virus were
shown to activate RIG-I and MDA5, and produce cytokines and
chemokines (Jacobs and Langland, 1996; St John et al., 2011;
Teijaro et al., 2011; Brown et al., 2012). Importantly, Graham et al.
(2013) found the inflammatory response of mast cells during IAV
infection occurred in a RIG-I-dependent mechanism. However,
the mechanism by which mast cells sense IAV infection is not
well understood. Here, for the first time we demonstrated that
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P815 mouse mastocytoma cells sensed influenza viruses mainly
via TLR3. In the present study, we found that blocking TLR3
with TLR3/dsRNA complex inhibitor in the P815 cells resulted
in decreased pro-inflammatory factors and viral titers. This data
suggested that activated TLR3 pathways were responsible for the
production of key pro-inflammatory cytokines and chemokines
in IAV infected mast cells. A recent study suggested that TLR3
could act as viral sensor to mediate viral transactivation via
upregulation of transcription factors such as c-Jun, which was
known to regulate the viral promoter activity (Bhargavan et al.,
2016). We recently also showed that IAV infection up-regulated
c-jun expression and activation (Xie et al., 2014). This could
partially explain that blocking TLR3 resulted in decreased IAV
growth.
Collectively, our data suggest that mast cells not only
participate in the IAV-induced immune response and
inflammation, but also actively serve as reservoirs for IAV
replication. Combined with we previously found that mast cells
escalated lung injury could be reduced dramatically by treatment
with ketotifen, which is a mast cell degranulation inhibitor (Hu
et al., 2012; Han et al., 2016). Thus, considering the critical role
of mast cells in IAV infection, this study provides insight for the
development of novel strategies to combat influenza infection by
targeting mast cells.
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